Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND5 pseudogene 1 (MTND5P1) is a non-functional genomic sequence similar to the MT-ND5 gene, which encodes a core catalytic subunit of mitochondrial respiratory chain complex I (NADH:ubiquinone oxidoreductase)[5][3]. Pseudogenes such as MTND5P1 originate from the transfer of mitochondrial DNA fragments to the nuclear genome, and are characterized by mutations and deletions that prevent them from encoding a functional protein[3]. While functional MT-ND5 plays a critical role in cellular energy production and mitochondrial disease, MTND5P1 does not encode a protein, is not a canonical molecular target, and has not been associated with a defined role in disease or as a biomarker. In recent literature, mitochondrial pseudogenes are sometimes studied as potential regulatory non-coding RNAs, but for MTND5P1, no such function or clinical application is documented[5][3].
None. As a pseudogene, it does not produce a functional molecule for drug targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND5 pseudogene 1 (MTND5P1).